{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T01:00:41Z","timestamp":1794186041131,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1C1C1013177"],"award-info":[{"award-number":["NRF-2021R1C1C1013177"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to detect safety signals of rebamipide and search for adverse events (AEs) of rebamipide that are more common than those of other drugs for peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD) in the elderly population. A total of 101,735 AE reports for drugs used to treat PUD and GERD between 2009 and 2018 from the KIDS-KAERS database (KIDS-KD) were used. Disproportionality analysis was performed to calculate the proportional reporting ratio (PRR), reporting odds ratio (ROR), and information component (IC). Drug labels in Korea, Japan, and China were reviewed to identify signals that have been listed. AEs frequently reported in the elderly population were also analyzed. Seriousness and median time to AEs were evaluated for statistically significant AEs. A total of 14 signals were detected, and 4 signals (dry mouth, dermatitis, purpura\/petechia, and fluid overload) were not listed on drug labels; however, they may be included as part of other listed AEs. In the elderly population, 11 AEs such as dyspepsia\/indigestion\/gastrointestinal distress, somnolence, dry mouth, and edema were common. These AEs were not serious and occurred within 2\u20139\u00a0days. This study identified possible AEs of rebamipide, a relatively safe drug.<\/jats:p>","DOI":"10.1038\/s41598-022-11505-0","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T11:03:10Z","timestamp":1652353390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Eunkyeong","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"4","key":"11505_CR1","first-page":"98","volume":"92","author":"VT Ivashkin","year":"2020","unstructured":"Ivashkin, V. T., Trukhmanov, A. S. & Gonik, M. I. Rebamipide using in gastroesophageal reflux disease treatment. Ter. Arkh. 92(4), 98\u2013104 (2020).","journal-title":"Ter. Arkh."},{"issue":"Suppl 1","key":"11505_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s10620-005-2800-9","volume":"50","author":"T Arakawa","year":"2005","unstructured":"Arakawa, T. et al. 15th anniversary of rebamipide: Looking ahead to the new mechanisms and new applications. Dig. Dis. Sci. 50(Suppl 1), S3\u2013S11 (2005).","journal-title":"Dig. Dis. Sci."},{"key":"11505_CR3","unstructured":"Dailypharm. [2020 Prescription Drug Market] Rebamipide. http:\/\/www.dailypharm.com\/Users\/News\/NewsView.html?DAILYPHARM_MOBILE=ok&ID=273120?DAILYPHARM_MOBILE=ok. Accessed 12 April 2022 (2021)."},{"key":"11505_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/1751-2980.13075","volume":"23","author":"BR Yang","year":"2021","unstructured":"Yang, B. R., Lee, J. Y. & Kim, M. G. The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid-related diseases: An analysis of national pharmacovigilance database in South Korea. J. Dig. Dis. 23, 118\u2013123 (2021).","journal-title":"J. Dig. Dis."},{"key":"11505_CR5","unstructured":"Korean Statistical Information Service. Status of Health Insurance Benefits of Frequent Diseases by Disease Subclassification of the Elderly Aged 65 or Older. https:\/\/kosis.kr\/statHtml\/statHtml.do?orgId=350&tblId=DT_35001_A667412&vw_cd=MT_ZTITLE&list_id=350_35001_6&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=K1&path=%25EB%25B3%25B4%25EA%25B1%25B. Accessed 1 March 2022 (2021)."},{"issue":"9","key":"11505_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes, M. L., Fixen, D. R. & Linnebur, S. A. Adverse effects of proton-pump inhibitor use in older adults: A review of the evidence. Ther. Adv. Drug Saf. 8(9), 273\u2013297 (2017).","journal-title":"Ther. Adv. Drug Saf."},{"key":"11505_CR7","doi-asserted-by":"crossref","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 67(4), 674\u2013694 (2019).","DOI":"10.1111\/jgs.15767"},{"issue":"11","key":"11505_CR8","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.1016\/S1470-2045(16)30312-6","volume":"17","author":"PJ Pitts","year":"2016","unstructured":"Pitts, P. J., Louet, H. L., Moride, Y. & Conti, R. M. 21st century pharmacovigilance: Efforts, roles, and responsibilities. Lancet Oncol. 17(11), e486\u2013e492 (2016).","journal-title":"Lancet Oncol."},{"issue":"9237","key":"11505_CR9","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards, I. R. & Aronson, J. K. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356(9237), 1255\u20131259 (2000).","journal-title":"Lancet"},{"issue":"3","key":"11505_CR10","doi-asserted-by":"publisher","first-page":"146045822110330","DOI":"10.1177\/14604582211033014","volume":"27","author":"H Shin","year":"2021","unstructured":"Shin, H., Cha, J., Lee, Y., Kim, J. Y. & Lee, S. Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm. Health Inform. J. 27(3), 14604582211033014 (2021).","journal-title":"Health Inform. J."},{"key":"11505_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2020245","author":"W Song","year":"2021","unstructured":"Song, W., Shi, L., Wang, Y. & Zhang, Z. Proton pump inhibitors and increased reporting odds of renal neoplasms: FAERS-based adverse event data mining and analysis. Expert Opin. Drug Saf. https:\/\/doi.org\/10.1080\/14740338.2022.2020245 (2021).","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"11505_CR12","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1038\/s41598-021-90108-7","volume":"11","author":"B Wu","year":"2021","unstructured":"Wu, B. et al. A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data. Sci. Rep. 11(1), 10709 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"11505_CR13","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1038\/s41598-021-83099-y","volume":"11","author":"B Wu","year":"2021","unstructured":"Wu, B. et al. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: Data mining of US FDA adverse event reporting system. Sci. Rep. 11(1), 3690 (2021).","journal-title":"Sci. Rep."},{"key":"11505_CR14","doi-asserted-by":"publisher","first-page":"648164","DOI":"10.3389\/fmed.2021.648164","volume":"8","author":"Y Zeng","year":"2021","unstructured":"Zeng, Y., Dai, Y., Zhou, Z., Yu, X. & Shi, D. Hepatotoxicity-related adverse effects of proton pump inhibitors: A cross-sectional study of signal mining and analysis of the FDA Adverse Event Report System Database. Front. Med. 8, 648164 (2021).","journal-title":"Front. Med."},{"issue":"1","key":"11505_CR15","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1038\/s41598-022-06611-y","volume":"12","author":"T Imai","year":"2022","unstructured":"Imai, T., Hazama, K., Kosuge, Y., Suzuki, S. & Ootsuka, S. Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADER. Sci. Rep. 12(1), 2631 (2022).","journal-title":"Sci. Rep."},{"issue":"2","key":"11505_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1590\/0034-7167-2018-0132","volume":"72","author":"AKA Garcia","year":"2019","unstructured":"Garcia, A. K. A., Fonseca, L. F., Furuya, R. K., Rabelo, P. D. & Rossetto, E. G. Effect of chewing gum on thirst: An integrative review. Rev. Bras. Enferm. 72(2), 484\u2013493 (2019).","journal-title":"Rev. Bras. Enferm."},{"key":"11505_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12948-016-0045-0","volume":"14","author":"MR Yacoub","year":"2016","unstructured":"Yacoub, M. R. et al. Drug induced exfoliative dermatitis: State of the art. Clin. Mol. Allergy 14, 9 (2016).","journal-title":"Clin. Mol. Allergy"},{"key":"11505_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cod.14016","volume":"86","author":"AC de Groot","year":"2021","unstructured":"de Groot, A. C. Systemic allergic dermatitis (systemic contact dermatitis) from pharmaceutical drugs: A review. Contact Dermatitis 86, 145\u2013164 (2021).","journal-title":"Contact Dermatitis"},{"issue":"12","key":"11505_CR19","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1515\/cclm-2019-0380","volume":"57","author":"PJ Vinholt","year":"2019","unstructured":"Vinholt, P. J. The role of platelets in bleeding in patients with thrombocytopenia and hematological disease. Clin. Chem. Lab. Med. 57(12), 1808\u20131817 (2019).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"33","key":"11505_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021497","volume":"99","author":"PR Padala","year":"2020","unstructured":"Padala, P. R. et al. Selective serotonin reuptake inhibitors-associated apathy syndrome: A cross sectional study. Medicine 99(33), e21497 (2020).","journal-title":"Medicine"},{"issue":"7","key":"11505_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","volume":"14","author":"JN Panicker","year":"2015","unstructured":"Panicker, J. N., Fowler, C. J. & Kessler, T. M. Lower urinary tract dysfunction in the neurological patient: Clinical assessment and management. Lancet Neurol. 14(7), 720\u2013732 (2015).","journal-title":"Lancet Neurol."},{"key":"11505_CR22","unstructured":"Tang, I. T., Shepp, D. H. Herpes simplex virus infection in cancer patients: prevention and treatment. Oncology (Williston Park) 6(7), 101\u2013106, 109; discussion 9\u201310 (1992)."},{"issue":"4","key":"11505_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/07853899309147293","volume":"25","author":"P Ljungman","year":"1993","unstructured":"Ljungman, P. Herpes virus infections in immunocompromised patients: Problems and therapeutic interventions. Ann. Med. 25(4), 329\u2013333 (1993).","journal-title":"Ann. Med."},{"issue":"2","key":"11505_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.ackd.2016.11.016","volume":"24","author":"CC Nast","year":"2017","unstructured":"Nast, C. C. Medication-induced interstitial nephritis in the 21st century. Adv. Chronic Kidney Dis. 24(2), 72\u201379 (2017).","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"4","key":"11505_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.mayocp.2018.01.020","volume":"93","author":"A Kanwar","year":"2018","unstructured":"Kanwar, A., Thaden, J. J. & Nkomo, V. T. Management of patients with aortic valve stenosis. Mayo Clin. Proc. 93(4), 488\u2013508 (2018).","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"11505_CR26","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s42003-021-02861-0","volume":"4","author":"Y Qian","year":"2021","unstructured":"Qian, Y. et al. Observational and genetic evidence highlight the association of human sleep behaviors with the incidence of fracture. Commun. Biol. 4(1), 1339 (2021).","journal-title":"Commun. Biol."},{"issue":"3","key":"11505_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13651501.2014.907919","volume":"18","author":"PG Ozdemir","year":"2014","unstructured":"Ozdemir, P. G. et al. Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety. Int. J. Psychiatry Clin. Pract. 18(3), 161\u2013168 (2014).","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"2","key":"11505_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","volume":"65","author":"L Bielory","year":"2005","unstructured":"Bielory, L., Lien, K. W. & Bigelsen, S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs 65(2), 215\u2013228 (2005).","journal-title":"Drugs"},{"issue":"3","key":"11505_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3349\/ymj.2017.58.3.564","volume":"58","author":"K Park","year":"2017","unstructured":"Park, K. et al. Signal detection of imipenem compared to other drugs from Korea Adverse Event Reporting System Database. Yonsei Med. J. 58(3), 564\u2013569 (2017).","journal-title":"Yonsei Med. J."},{"issue":"2","key":"11505_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2125.2003.01968.x","volume":"57","author":"AM Wilson","year":"2004","unstructured":"Wilson, A. M., Thabane, L. & Holbrook, A. Application of data mining techniques in pharmacovigilance. Br. J. Clin. Pharmacol. 57(2), 127\u2013134 (2004).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"11505_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/pds.771","volume":"12","author":"AL Gould","year":"2003","unstructured":"Gould, A. L. Practical pharmacovigilance analysis strategies. Pharmacoepidemiol. Drug Saf. 12(7), 559\u2013574 (2003).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"11505_CR32","first-page":"90","volume":"21","author":"J Kim","year":"2011","unstructured":"Kim, J., Oh, J. M., Son, S. H. & Shin, W. G. Use of information component (IC) and relative risk (RR) for signal detection of drug interactions of clopidogrel: Data-mining study using Health Insurance Review & Assessment Service (HIRA) claims database. Korean J. Clin. Pharm. 21(2), 90\u201399 (2011).","journal-title":"Korean J. Clin. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11505-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:41:00Z","timestamp":1669344060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11505-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11505"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11505-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7839"}}